About the Company
We do not have any company description for Aspira Women's Health Inc. at the moment.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Aspira Women's Health Inc.
Aspira Women’s Health, Inc. Received a $1 MM Loan Forgiveness and 6 ...
As a result of the loan forgiveness and deferrals, the Company expects cash outflows for the year ending December 31, 2023, to be reduced by $247,000. About Aspira Women’s Health Inc.
Aspira Women's Health Inc. Announces Receipt of Delisting Notification ...
Aspira Women's Health Inc. is dedicated to the discovery, development, and commercialization of noninvasive, AI-powered tests to aid in the diagnosis of gynecologic diseases.
Aspira Women's Health: Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update
AUSTIN, TX / ACCESS Newswire / August 13, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive ...
Aspira Women’s Health Inc. to Begin Trading April 17th On ... - Nasdaq
SHELTON, CT/ ACCESS Newswire/ April 17, 2025/ Aspira Women's Health Inc., a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today ...
Aspira Women's Health Announces Appointment of Ellen Beausang ... - Nasdaq
AUSTIN, TX/ ACCESS Newswire/ February 11, 2025/ Aspira Women's Health Inc., a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today ...
StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH)
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor.
Aspira Women's Health Inc. Company & People | AWHL | Barron's
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor.
Why Aspira Women's Health (AWH) Stock Is Skyrocketing
Aspira Women's Health shares are trading higher by 64% during Tuesday's session. The company secured $1.37 million through a private placement. This simple system has nailed 1,000+ post-earnings ...
Aspira Women’s Health Inc. to Begin Trading April 17th On OTC Under ...
Aspira Women's Health Inc. is dedicated to the discovery, development, and commercialization of noninvasive, AI-powered tests to aid in the diagnosis of gynecologic diseases.
Similar Companies
Loading the latest forecasts...